AB Science S.A., 2026-07-17
An SEC Form D private-offering notice from Paris, a $2,016,160 filer-stated offering target in Biotech. Filed 2026-07-17. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
AB Science is a publicly traded, France based clinical stage biopharmaceutical company developing targeted therapies, including tyrosine kinase inhibitors, for cancers, chronic inflammatory diseases and neurodegenerative disorders.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Precision Peptide Co Inc., 2026-07-20, $883K, Surrey, BC, Canada
- Principal Technologies Inc., 2026-07-17, $92K, Vancouver, BC, Canada
- Aspicio Therapeutics, Inc., 2026-07-17, $200K, Downingtown, PA
- Sinopia Biosciences, Inc., 2026-07-16, $4.3M, San Diego, CA
- CellTrack Corp, 2026-07-16, $600K, Madison, WI
- OS Therapies Inc, 2026-07-16, $9.2M, Grasonville, MD
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.